
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Topic 09 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 31 - 15 Topics</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

tr:nth-child(even){background-color: #f2f2f2;}

tr:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Topic 09 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 31 - 15 Topics</h2>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>cite ad</th>
      <th>title</th>
      <th>authors</th>
      <th>publish year</th>
      <th>publish time</th>
      <th>dataset</th>
      <th>abstract mentions covid</th>
      <th>pmcid</th>
      <th>pubmed id</th>
      <th>doi</th>
      <th>cord uid</th>
      <th>topic weight</th>
      <th>Similarity scispacy</th>
      <th>Similarity specter</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="7egcrqz0";>1</th>
      <td>Bardhi_2017</td>
      <td>Potent In Vivo NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein</td>
      <td>Bardhi, Ariola; Wu, Yanling; Chen, Weizao; Li, Wei; Zhu, Zhongyu; Zheng, Jian Hua; Wong, Hing; Jeng, Emily; Jones, Jennifer; Ochsenbauer, Christina; Kappes, John C.; Dimitrov, Dimiter S.; Ying, Tianlei; Goldstein, Harris</td>
      <td>2017</td>
      <td>2017-08-09</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625480" target="_blank">PMC5625480</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28794022.0" target="_blank">28794022.0</a></td>
      <td><a href="https://doi.org/10.1128/jvi.00937-17" target="_blank">10.1128/jvi.00937-17</a></td>
      <td>7egcrqz0</td>
      <td>0.889653</td>
      <td><a href="Topic_02.html#glm2dxhh">Hwang_2015</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="3ewcgpxj";>2</th>
      <td>Chou_2012</td>
      <td>Palmitate-derivatized human IL-2: a potential anti-cancer immunotherapeutic of low systemic toxicity</td>
      <td>Chou, Sharon H.; Shetty, Aditya V.; Geng, Yajun; Xu, Lipeng; Munirathinam, Gnanasekar; Pipathsouk, Anne; Tan, Isaiah; Morris, Timothy; Wang, Bin; Chen, Aoshuang; Zheng, Guoxing</td>
      <td>2012</td>
      <td>2012-11-04</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393711" target="_blank">PMC4393711</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/23124508.0" target="_blank">23124508.0</a></td>
      <td><a href="https://doi.org/10.1007/s00262-012-1364-8" target="_blank">10.1007/s00262-012-1364-8</a></td>
      <td>3ewcgpxj</td>
      <td>0.888942</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_06.html#pd2min1o">Li_X_2017</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_02.html#jwglalgx">Zuo_J_2009</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="zbxiaofl";>3</th>
      <td>Tseng_2008</td>
      <td>Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination</td>
      <td>Tseng, Chih-Wen; Monie, Archana; Wu, Chao-Yi; Huang, Bruce; Wang, Mei-Cheng; Hung, Chien-Fu; Wu, T.-C.</td>
      <td>2008</td>
      <td>2008-06-10</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535907" target="_blank">PMC2535907</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/18542898.0" target="_blank">18542898.0</a></td>
      <td><a href="https://doi.org/10.1007/s00109-008-0370-y" target="_blank">10.1007/s00109-008-0370-y</a></td>
      <td>zbxiaofl</td>
      <td>0.843052</td>
      <td><a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a></td>
      <td><a href="Topic_09.html#ifnc53my">Peng_2011</a>, <a href="Topic_09.html#xndxn1r3">Chuang_2010</a>, <a href="Topic_09.html#bbqx2lxw">Suarez_2016</a></td>
    </tr>
    <tr>
      <th id="h75jdmrb";>4</th>
      <td>Wang_2013</td>
      <td>Fully Phosphorothioate-Modified CpG ODN with PolyG Motif Inhibits the Adhesion of B16 Melanoma Cells In Vitro and Tumorigenesis In Vivo</td>
      <td>Wang, Xueju; Wang, Liying; Wan, Min; Wu, Xiuli; Yu, Yongli; Wang, Liping</td>
      <td>2013</td>
      <td>2013-08-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723239" target="_blank">PMC3723239</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/23848522.0" target="_blank">23848522.0</a></td>
      <td><a href="https://doi.org/10.1089/nat.2013.0419" target="_blank">10.1089/nat.2013.0419</a></td>
      <td>h75jdmrb</td>
      <td>0.838836</td>
      <td></td>
      <td><a href="Topic_09.html#sxidmw7e">Sun_W_2016</a></td>
    </tr>
    <tr>
      <th id="xndxn1r3";>5</th>
      <td>Chuang_2010</td>
      <td>Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination</td>
      <td>Chuang, Chi-Mu; Monie, Archana; Hung, Chien-Fu; Wu, T-C</td>
      <td>2010</td>
      <td>2010-04-28</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873498" target="_blank">PMC2873498</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/20426849.0" target="_blank">20426849.0</a></td>
      <td><a href="https://doi.org/10.1186/1423-0127-17-32" target="_blank">10.1186/1423-0127-17-32</a></td>
      <td>xndxn1r3</td>
      <td>0.820278</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_02.html#wdbrxpmz">Swiecki_2010</a></td>
      <td><a href="Topic_09.html#ifnc53my">Peng_2011</a>, <a href="Topic_09.html#zbxiaofl">Tseng_2008</a></td>
    </tr>
    <tr>
      <th id="zdb0xjic";>6</th>
      <td>Yu_S_2015</td>
      <td>BAP31, a promising target for the immunotherapy of malignant melanomas</td>
      <td>Yu, Shaojuan; Wang, Fuli; Fan, Li; Wei, Yuying; Li, Haitao; Sun, Yuanjie; Yang, Angang; Jin, Boquan; Song, Chaojun; Yang, Kun</td>
      <td>2015</td>
      <td>2015-04-18</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405826" target="_blank">PMC4405826</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25903101.0" target="_blank">25903101.0</a></td>
      <td><a href="https://doi.org/10.1186/s13046-015-0153-6" target="_blank">10.1186/s13046-015-0153-6</a></td>
      <td>zdb0xjic</td>
      <td>0.765761</td>
      <td></td>
      <td><a href="Topic_09.html#ifnc53my">Peng_2011</a>, <a href="Topic_09.html#xndxn1r3">Chuang_2010</a>, <a href="Topic_09.html#zbxiaofl">Tseng_2008</a></td>
    </tr>
    <tr>
      <th id="4jycukj3";>7</th>
      <td>Sher_2015</td>
      <td>A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model</td>
      <td>Sher, Yuh-Pyng; Lin, Su-I; Chen, I-Hua; Liu, Hsin-Yu; Lin, Chen-Yuan; Chiang, I-Ping; Roffler, Steve; Chen, Hsin-Wei; Liu, Shih-Jen</td>
      <td>2015</td>
      <td>2015-11-26</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808025" target="_blank">PMC4808025</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26621839.0" target="_blank">26621839.0</a></td>
      <td></td>
      <td>4jycukj3</td>
      <td>0.734438</td>
      <td><a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a></td>
      <td><a href="Topic_09.html#bbqx2lxw">Suarez_2016</a>, <a href="Topic_04.html#p5sa6k0j">Betting_2009</a></td>
    </tr>
    <tr>
      <th id="43bdjxe2";>8</th>
      <td>Han_T_2012</td>
      <td>Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma</td>
      <td>Han, Thomas; Abdel-Motal, Ussama M.; Chang, De-Kuan; Sui, Jianhua; Muvaffak, Asli; Campbell, James; Zhu, Quan; Kupper, Thomas S.; Marasco, Wayne A.</td>
      <td>2012</td>
      <td>2012-09-04</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433438" target="_blank">PMC3433438</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22973452.0" target="_blank">22973452.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0044455" target="_blank">10.1371/journal.pone.0044455</a></td>
      <td>43bdjxe2</td>
      <td>0.729011</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_02.html#jwglalgx">Zuo_J_2009</a>, <a href="Topic_02.html#wdbrxpmz">Swiecki_2010</a></td>
      <td><a href="Topic_09.html#bbqx2lxw">Suarez_2016</a>, <a href="Topic_09.html#fdw1qe9z">Lo_A_2014</a></td>
    </tr>
    <tr>
      <th id="01id7jq6";>9</th>
      <td>McLeod_2018</td>
      <td>Characterization of murine CEACAM1 in vivo reveals low expression on CD8(+) T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1</td>
      <td>McLeod, Robbie L.; Angagaw, Minilik H.; Baral, Toya Nath; Liu, Liming; Moniz, Raymond Joseph; Laskey, Jason; Hsieh, SuChun; Lee, Mike; Han, Jin-Hwan; Issafras, Hassan; Javaid, Sarah; Loboda, Andrey; Sadekova, Svetlana; O'Connor, Joann A.; Tse, Archie; Punnonen, Juha</td>
      <td>2018</td>
      <td>2018-10-02</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195382" target="_blank">PMC6195382</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30349641.0" target="_blank">30349641.0</a></td>
      <td><a href="https://doi.org/10.18632/oncotarget.26108" target="_blank">10.18632/oncotarget.26108</a></td>
      <td>01id7jq6</td>
      <td>0.721272</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_06.html#ivyp5cgz">Huang_2018</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a></td>
      <td><a href="Topic_09.html#bbqx2lxw">Suarez_2016</a></td>
    </tr>
    <tr>
      <th id="sxidmw7e";>10</th>
      <td>Sun_W_2016</td>
      <td>Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice</td>
      <td>Sun, Wei; Fang, Mingli; Chen, Yajing; Yang, Zhaogang; Xiao, Yue; Wan, Min; Wang, Hua; Yu, Yongli; Wang, Liying</td>
      <td>2016</td>
      <td>2016-01-05</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747877" target="_blank">PMC4747877</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26918036.0" target="_blank">26918036.0</a></td>
      <td><a href="https://doi.org/10.7150/jca.12899" target="_blank">10.7150/jca.12899</a></td>
      <td>sxidmw7e</td>
      <td>0.716150</td>
      <td><a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a></td>
      <td><a href="Topic_09.html#ifnc53my">Peng_2011</a>, <a href="Topic_09.html#4jycukj3">Sher_2015</a></td>
    </tr>
    <tr>
      <th id="ifnc53my";>11</th>
      <td>Peng_2011</td>
      <td>Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines</td>
      <td>Peng, Shiwen; Monie, Archana; Pang, Xiaowu; Hung, Chien-Fu; Wu, T-C</td>
      <td>2011</td>
      <td>2011-03-08</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062584" target="_blank">PMC3062584</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21385449.0" target="_blank">21385449.0</a></td>
      <td><a href="https://doi.org/10.1186/1423-0127-18-21" target="_blank">10.1186/1423-0127-18-21</a></td>
      <td>ifnc53my</td>
      <td>0.715522</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a></td>
      <td><a href="Topic_09.html#xndxn1r3">Chuang_2010</a>, <a href="Topic_09.html#zbxiaofl">Tseng_2008</a></td>
    </tr>
    <tr>
      <th id="4hm647sq";>12</th>
      <td>Chang_2016</td>
      <td>Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL</td>
      <td>Chang, De-Kuan; Kurella, Vinodh B.; Biswas, Subhabrata; Avnir, Yuval; Sui, Jianhua; Wang, Xueqian; Sun, Jiusong; Wang, Yanyan; Panditrao, Madhura; Peterson, Eric; Tallarico, Aimee; Fernandes, Stacey; Goodall, Margaret; Zhu, Quan; Brown, Jennifer R.; Jefferis, Roy; Marasco, Wayne A</td>
      <td>2016</td>
      <td>2016-03-10</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966851" target="_blank">PMC4966851</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26963739.0" target="_blank">26963739.0</a></td>
      <td><a href="https://doi.org/10.1080/19420862.2016.1159365" target="_blank">10.1080/19420862.2016.1159365</a></td>
      <td>4hm647sq</td>
      <td>0.703807</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#68inp2ps">Kim_T_2005</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_02.html#jwglalgx">Zuo_J_2009</a>, <a href="Topic_06.html#ivyp5cgz">Huang_2018</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="2qpw41ze";>13</th>
      <td>Ruiss_2011</td>
      <td>EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL</td>
      <td>Ruiss, Romana; Jochum, Simon; Mocikat, Ralph; Hammerschmidt, Wolfgang; Zeidler, Reinhard</td>
      <td>2011</td>
      <td>2011-10-10</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189918" target="_blank">PMC3189918</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22022385.0" target="_blank">22022385.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0025294" target="_blank">10.1371/journal.pone.0025294</a></td>
      <td>2qpw41ze</td>
      <td>0.685904</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_02.html#wdbrxpmz">Swiecki_2010</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a></td>
      <td><a href="Topic_05.html#v0kzuqdy">Martin_1989</a>, <a href="Topic_04.html#yw7cu976">Matsuo_2012</a></td>
    </tr>
    <tr>
      <th id="b49lvynx";>14</th>
      <td>Chen_2011</td>
      <td>Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8(+) T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice</td>
      <td>Chen, Y; Xie, Y; Chan, T; Sami, A; Ahmed, S; Liu, Q; Xiang, J</td>
      <td>2011</td>
      <td>2011-05-13</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091910" target="_blank">PMC7091910</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21566669.0" target="_blank">21566669.0</a></td>
      <td><a href="https://doi.org/10.1038/cgt.2011.18" target="_blank">10.1038/cgt.2011.18</a></td>
      <td>b49lvynx</td>
      <td>0.676767</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_09.html#4jycukj3">Sher_2015</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a></td>
      <td><a href="Topic_09.html#bbqx2lxw">Suarez_2016</a>, <a href="Topic_09.html#zbxiaofl">Tseng_2008</a>, <a href="Topic_09.html#ifnc53my">Peng_2011</a></td>
    </tr>
    <tr>
      <th id="e6h8n8qm";>15</th>
      <td>Muthumani_2017</td>
      <td>Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody</td>
      <td>Muthumani, Kar; Marnin, Liron; Kudchodkar, Sagar B.; Perales-Puchalt, Alfredo; Choi, Hyeree; Agarwal, Sangya; Scott, Veronica L.; Reuschel, Emma L.; Zaidi, Faraz I.; Duperret, Elizabeth K.; Wise, Megan C.; Kraynyak, Kimberly A.; Ugen, Kenneth. E.; Sardesai, Niranjan Y.; Joseph Kim, J.; Weiner, David B.</td>
      <td>2017</td>
      <td>2017-08-17</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676807" target="_blank">PMC5676807</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28819703.0" target="_blank">28819703.0</a></td>
      <td><a href="https://doi.org/10.1007/s00262-017-2042-7" target="_blank">10.1007/s00262-017-2042-7</a></td>
      <td>e6h8n8qm</td>
      <td>0.656209</td>
      <td></td>
      <td><a href="Topic_09.html#ifnc53my">Peng_2011</a>, <a href="Topic_04.html#p5sa6k0j">Betting_2009</a>, <a href="Topic_09.html#4jycukj3">Sher_2015</a></td>
    </tr>
    <tr>
      <th id="3ph033lw";>16</th>
      <td>Pilch_2019</td>
      <td>The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies</td>
      <td>Pilch, Zofia; Tonecka, Katarzyna; Skorzynski, Marcin; Sas, Zuzanna; Braniewska, Agata; Kryczka, Tomasz; Boon, Louis; Golab, Jakub; Meyaard, Linde; Rygiel, Tomasz P.</td>
      <td>2019</td>
      <td>2019-01-17</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336379" target="_blank">PMC6336379</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30653571.0" target="_blank">30653571.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0210796" target="_blank">10.1371/journal.pone.0210796</a></td>
      <td>3ph033lw</td>
      <td>0.650804</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a></td>
      <td><a href="Topic_09.html#ifnc53my">Peng_2011</a></td>
    </tr>
    <tr>
      <th id="2behvv3b";>17</th>
      <td>Kondou_2019</td>
      <td>Recombinant baculovirus expressing the FrC-OVA protein induces protective antitumor immunity in an EG7-OVA mouse model</td>
      <td>Kondou, Keigo; Suzuki, Tomoyuki; Chang, Myint Oo; Takaku, Hiroshi</td>
      <td>2019</td>
      <td>2019-10-22</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805443" target="_blank">PMC6805443</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31649751.0" target="_blank">31649751.0</a></td>
      <td><a href="https://doi.org/10.1186/s13036-019-0207-y" target="_blank">10.1186/s13036-019-0207-y</a></td>
      <td>2behvv3b</td>
      <td>0.631206</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="bbqx2lxw";>18</th>
      <td>Suarez_2016</td>
      <td>Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model</td>
      <td>Suarez, Eloah Rabello; Chang, De-Kuan; Sun, Jiusong; Sui, Jianhua; Freeman, Gordon J.; Signoretti, Sabina; Zhu, Quan; Marasco, Wayne A.</td>
      <td>2016</td>
      <td>2016-04-29</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085160" target="_blank">PMC5085160</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27145284.0" target="_blank">27145284.0</a></td>
      <td><a href="https://doi.org/10.18632/oncotarget.9114" target="_blank">10.18632/oncotarget.9114</a></td>
      <td>bbqx2lxw</td>
      <td>0.607229</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_06.html#k751ryv4">Zhao_2011</a></td>
      <td><a href="Topic_09.html#fdw1qe9z">Lo_A_2014</a>, <a href="Topic_09.html#zbxiaofl">Tseng_2008</a>, <a href="Topic_09.html#hpuj1nvp">Wang_2019</a></td>
    </tr>
    <tr>
      <th id="okpdkjd3";>19</th>
      <td>Peng_2014</td>
      <td>Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells</td>
      <td>Peng, Shiwen; Song, Liwen; Knoff, Jayne; Wang, Joshua W; Chang, Yung-Nien; Hannaman, Drew; Wu, T-C; Alvarez, Ronald D; Roden, Richard BS; Hung, Chien-Fu</td>
      <td>2014</td>
      <td>2014-03-04</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015858" target="_blank">PMC4015858</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/24594273.0" target="_blank">24594273.0</a></td>
      <td><a href="https://doi.org/10.1186/2045-3701-4-11" target="_blank">10.1186/2045-3701-4-11</a></td>
      <td>okpdkjd3</td>
      <td>0.589792</td>
      <td><a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#k751ryv4">Zhao_2011</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="xpeqin1b";>20</th>
      <td>Dai_S_2006</td>
      <td>Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells</td>
      <td>Dai, Shengming; Zhou, Xiangyang; Wang, Baomei; Wang, Qingqing; Fu, Yangxin; Chen, Taoyong; Wan, Tao; Yu, Yizhi; Cao, Xuetao</td>
      <td>2006</td>
      <td>2006-09-26</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079873" target="_blank">PMC7079873</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/17016692.0" target="_blank">17016692.0</a></td>
      <td><a href="https://doi.org/10.1007/s00109-006-0102-0" target="_blank">10.1007/s00109-006-0102-0</a></td>
      <td>xpeqin1b</td>
      <td>0.588928</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a></td>
      <td><a href="Topic_01.html#ctikde7d">Cervantes-Barragan_2010</a>, <a href="Topic_09.html#4jycukj3">Sher_2015</a>, <a href="Topic_04.html#855h0e1k">Perez-Shibayama_2013</a></td>
    </tr>
    <tr>
      <th id="hpuj1nvp";>21</th>
      <td>Wang_2019</td>
      <td>The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy</td>
      <td>Wang, Yu; Zhang, Hui; He, You-Wen</td>
      <td>2019</td>
      <td>2019-07-19</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658873" target="_blank">PMC6658873</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31379815.0" target="_blank">31379815.0</a></td>
      <td><a href="https://doi.org/10.3389/fimmu.2019.01574" target="_blank">10.3389/fimmu.2019.01574</a></td>
      <td>hpuj1nvp</td>
      <td>0.515590</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a></td>
      <td><a href="Topic_09.html#bbqx2lxw">Suarez_2016</a>, <a href="Topic_09.html#zbxiaofl">Tseng_2008</a>, <a href="Topic_09.html#ifnc53my">Peng_2011</a></td>
    </tr>
    <tr>
      <th id="517h27hc";>22</th>
      <td>Li_W_2017</td>
      <td>One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells</td>
      <td>Li, Wei; Wu, Yanling; Kong, Desheng; Yang, Hongjia; Wang, Yanping; Shao, Jiping; Feng, Yang; Chen, Weizao; Ma, Liying; Ying, Tianlei; Dimitrov, Dimiter S.</td>
      <td>2017</td>
      <td>2017-08-22</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567353" target="_blank">PMC5567353</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28831040.0" target="_blank">28831040.0</a></td>
      <td><a href="https://doi.org/10.1038/s41598-017-07966-3" target="_blank">10.1038/s41598-017-07966-3</a></td>
      <td>517h27hc</td>
      <td>0.512283</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_02.html#wdbrxpmz">Swiecki_2010</a>, <a href="Topic_06.html#k751ryv4">Zhao_2011</a></td>
      <td><a href="Topic_09.html#7egcrqz0">Bardhi_2017</a></td>
    </tr>
    <tr>
      <th id="d2mb2b3d";>23</th>
      <td>Kortylewski_2009</td>
      <td>TLR agonist–Stat3 siRNA conjugates: cell-specific gene silencing and enhanced antitumor immune responses</td>
      <td>Kortylewski, Marcin; Swiderski, Piotr; Herrmann, Andreas; Wang, Lin; Kowolik, Claudia; Kujawski, Maciej; Lee, Heehyoung; Scuto, Anna; Liu, Yong; Yang, Chunmei; Deng, Jiehui; Soifer, Harris S.; Raubitschek, Andrew; Forman, Stephen; Rossi, John J.; Pardoll, Drew M.; Jove, Richard; Yu, Hua</td>
      <td>2009</td>
      <td>2009-09-13</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846721" target="_blank">PMC2846721</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19749770.0" target="_blank">19749770.0</a></td>
      <td><a href="https://doi.org/10.1038/nbt.1564" target="_blank">10.1038/nbt.1564</a></td>
      <td>d2mb2b3d</td>
      <td>0.507931</td>
      <td><a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a></td>
      <td><a href="Topic_09.html#4jycukj3">Sher_2015</a>, <a href="Topic_09.html#ifnc53my">Peng_2011</a>, <a href="Topic_09.html#sxidmw7e">Sun_W_2016</a>, <a href="Topic_01.html#ctikde7d">Cervantes-Barragan_2010</a></td>
    </tr>
    <tr>
      <th id="g0vm865g";>24</th>
      <td>Yaguchi_2017</td>
      <td>Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses</td>
      <td>Yaguchi, Tomonori; Kobayashi, Asuka; Inozume, Takashi; Morii, Kenji; Nagumo, Haruna; Nishio, Hiroshi; Iwata, Takashi; Ka, Yuyo; Katano, Ikumi; Ito, Ryoji; Ito, Mamoru; Kawakami, Yutaka</td>
      <td>2017</td>
      <td>2017-11-20</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207709" target="_blank">PMC6207709</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/29151581.0" target="_blank">29151581.0</a></td>
      <td><a href="https://doi.org/10.1038/cmi.2017.106" target="_blank">10.1038/cmi.2017.106</a></td>
      <td>g0vm865g</td>
      <td>0.475160</td>
      <td><a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#k751ryv4">Zhao_2011</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_02.html#jwglalgx">Zuo_J_2009</a></td>
      <td><a href="Topic_01.html#ctikde7d">Cervantes-Barragan_2010</a></td>
    </tr>
    <tr>
      <th id="fdw1qe9z";>25</th>
      <td>Lo_A_2014</td>
      <td>Regression of established renal cell carcinoma in nude mice using lentivirus-transduced human T cells expressing a human anti-CAIX chimeric antigen receptor</td>
      <td>Lo, Agnes Shuk-Yee; Xu, Chen; Murakami, Akikazu; Marasco, Wayne A</td>
      <td>2014</td>
      <td>2014-12-10</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782938" target="_blank">PMC4782938</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27119093.0" target="_blank">27119093.0</a></td>
      <td><a href="https://doi.org/10.1038/mto.2014.3" target="_blank">10.1038/mto.2014.3</a></td>
      <td>fdw1qe9z</td>
      <td>0.447189</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_06.html#ivyp5cgz">Huang_2018</a></td>
      <td><a href="Topic_09.html#bbqx2lxw">Suarez_2016</a>, <a href="Topic_09.html#43bdjxe2">Han_T_2012</a>, <a href="Topic_09.html#01id7jq6">McLeod_2018</a></td>
    </tr>
    <tr>
      <th id="gth58p4s";>26</th>
      <td>Allam_2015</td>
      <td>T(FH) cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1</td>
      <td>Allam, Atef; Majji, Sai; Peachman, Kristina; Jagodzinski, Linda; Kim, Jiae; Ratto-Kim, Silvia; Wijayalath, Wathsala; Merbah, Melanie; Kim, Jerome H.; Michael, Nelson L.; Alving, Carl R.; Casares, Sofia; Rao, Mangala</td>
      <td>2015</td>
      <td>2015-06-02</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451806" target="_blank">PMC4451806</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26034905.0" target="_blank">26034905.0</a></td>
      <td><a href="https://doi.org/10.1038/srep10443" target="_blank">10.1038/srep10443</a></td>
      <td>gth58p4s</td>
      <td>0.440735</td>
      <td><a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_02.html#68inp2ps">Kim_T_2005</a></td>
      <td><a href="Topic_06.html#3qemb0x3">Li_L_2011</a></td>
    </tr>
    <tr>
      <th id="5yb336oz";>27</th>
      <td>Yokomine_2009</td>
      <td>The forkhead box M1 transcription factor as a candidate of target for anti‐cancer immunotherapy</td>
      <td>Yokomine, Kazunori; Senju, Satoru; Nakatsura, Tetsuya; Irie, Atsushi; Hayashida, Yuki; Ikuta, Yoshiaki; Harao, Michiko; Imai, Katsunori; Baba, Hideo; Iwase, Hirotaka; Nomori, Hiroaki; Takahashi, Koji; Daigo, Yataro; Tsunoda, Takuya; Nakamura, Yusuke; Sasaki, Yutaka; Nishimura, Yasuharu</td>
      <td>2009</td>
      <td>2009-08-17</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165995" target="_blank">PMC7165995</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19688828.0" target="_blank">19688828.0</a></td>
      <td><a href="https://doi.org/10.1002/ijc.24836" target="_blank">10.1002/ijc.24836</a></td>
      <td>5yb336oz</td>
      <td>0.428704</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="8t0jvrts";>28</th>
      <td>Gilbert_2011</td>
      <td>Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies</td>
      <td>Gilbert, Amy E.; Karagiannis, Panagiotis; Dodev, Tihomir; Koers, Alexander; Lacy, Katie; Josephs, Debra H.; Takhar, Pooja; Geh, Jenny L. C.; Healy, Ciaran; Harries, Mark; Acland, Katharine M.; Rudman, Sarah M.; Beavil, Rebecca L.; Blower, Philip J.; Beavil, Andrew J.; Gould, Hannah J.; Spicer, James; Nestle, Frank O.; Karagiannis, Sophia N.</td>
      <td>2011</td>
      <td>2011-04-29</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084832" target="_blank">PMC3084832</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21559411.0" target="_blank">21559411.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0019330" target="_blank">10.1371/journal.pone.0019330</a></td>
      <td>8t0jvrts</td>
      <td>0.418106</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a></td>
      <td><a href="Topic_09.html#hpuj1nvp">Wang_2019</a>, <a href="Topic_09.html#bbqx2lxw">Suarez_2016</a></td>
    </tr>
    <tr>
      <th id="u8h515fh";>29</th>
      <td>Hossain_2012</td>
      <td>A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma</td>
      <td>Hossain, Azim; Radwan, Faisal F. Y.; Doonan, Bently P.; God, Jason M.; Zhang, Lixia; Bell, Darwin P.; Haque, Azizul</td>
      <td>2012</td>
      <td>2012-07-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747633" target="_blank">PMC3747633</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22847295.0" target="_blank">22847295.0</a></td>
      <td><a href="https://doi.org/10.1007/s10495-012-0745-y" target="_blank">10.1007/s10495-012-0745-y</a></td>
      <td>u8h515fh</td>
      <td>0.411410</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_10.html#gozr10io">Bernardini_2012</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="gnnykgs8";>30</th>
      <td>Oft_M_2019</td>
      <td>Immune regulation and cytotoxic T cell activation of IL-10 agonists – Preclinical and clinical experience</td>
      <td>Oft, Martin</td>
      <td>2019</td>
      <td>2019-08-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129358" target="_blank">PMC7129358</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31706853.0" target="_blank">31706853.0</a></td>
      <td><a href="https://doi.org/10.1016/j.smim.2019.101325" target="_blank">10.1016/j.smim.2019.101325</a></td>
      <td>gnnykgs8</td>
      <td>0.409300</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_06.html#k751ryv4">Zhao_2011</a></td>
      <td><a href="Topic_09.html#zbxiaofl">Tseng_2008</a>, <a href="Topic_09.html#hpuj1nvp">Wang_2019</a></td>
    </tr>
    <tr>
      <th id="u0ys2xcm";>31</th>
      <td>Zhang_2007</td>
      <td>TAP expression reduces IL‐10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma</td>
      <td>Zhang, Qian‐Jin; Seipp, Robyn P.; Chen, Susan S.; Vitalis, Timothy Z.; Li, Xiao‐Lin; Choi, Kyung‐Bok; Jeffries, Andrew; Jefferies, Wilfred A.</td>
      <td>2007</td>
      <td>2007-02-02</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165830" target="_blank">PMC7165830</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/17278102.0" target="_blank">17278102.0</a></td>
      <td><a href="https://doi.org/10.1002/ijc.22371" target="_blank">10.1002/ijc.22371</a></td>
      <td>u0ys2xcm</td>
      <td>0.376715</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="6y3xvmds";>32</th>
      <td>Yang_2012</td>
      <td>MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice</td>
      <td>Yang, Ming; Yan, Youyou; Fang, Mingli; Wan, Min; Wu, Xiuli; Zhang, Xiaoling; Zhao, Tiesuo; Wei, Hongfei; Song, Dandan; Wang, Liying; Yu, Yongli</td>
      <td>2012</td>
      <td>2012-08-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106219" target="_blank">PMC7106219</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22595192.0" target="_blank">22595192.0</a></td>
      <td><a href="https://doi.org/10.1016/j.intimp.2012.05.003" target="_blank">10.1016/j.intimp.2012.05.003</a></td>
      <td>6y3xvmds</td>
      <td>0.371318</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_02.html#wdbrxpmz">Swiecki_2010</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="onq5f40g";>33</th>
      <td>Hangalapura_2011</td>
      <td>Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an Adenovirus based melanoma vaccine</td>
      <td>Hangalapura, Basav N; Oosterhoff, Dinja; Gupta, Tarun; de Groot, Jan; Wijnands, Pepijn GJTB; van Beusechem, Victor W.; den Haan, Joke; Tüting, Thomas; van den Eertwegh, Alfons JM; Curiel, David T; Scheper, Rik J; de Gruijl, Tanja D</td>
      <td>2011</td>
      <td>2011-03-09</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058128" target="_blank">PMC3058128</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21272606.0" target="_blank">21272606.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2011.01.022" target="_blank">10.1016/j.vaccine.2011.01.022</a></td>
      <td>onq5f40g</td>
      <td>0.370517</td>
      <td><a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_02.html#wdbrxpmz">Swiecki_2010</a></td>
      <td><a href="Topic_09.html#ifnc53my">Peng_2011</a></td>
    </tr>
    <tr>
      <th id="p5sa6k0j";>34</th>
      <td>Betting_2009</td>
      <td>Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells</td>
      <td>Betting, David J.; Mu, Xi Y.; Kafi, Kamran; McDonnel, Desmond; Rosas, Francisco; Gold, Daniel P.; Timmerman, John M.</td>
      <td>2009</td>
      <td>2009-01-07</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683685" target="_blank">PMC2683685</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19000731.0" target="_blank">19000731.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2008.10.055" target="_blank">10.1016/j.vaccine.2008.10.055</a></td>
      <td>p5sa6k0j</td>
      <td>0.366015</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_02.html#wdbrxpmz">Swiecki_2010</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#k751ryv4">Zhao_2011</a></td>
      <td><a href="Topic_04.html#yw7cu976">Matsuo_2012</a>, <a href="Topic_01.html#ctikde7d">Cervantes-Barragan_2010</a></td>
    </tr>
    <tr>
      <th id="9v9tfhnd";>35</th>
      <td>Murphy_2016</td>
      <td>CD8 T Cell–Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas</td>
      <td>Murphy, Katherine A.; Griffith, Thomas S.</td>
      <td>2016</td>
      <td>2016-07-27</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999780" target="_blank">PMC4999780</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27472363.0" target="_blank">27472363.0</a></td>
      <td><a href="https://doi.org/10.3390/cancers8080071" target="_blank">10.3390/cancers8080071</a></td>
      <td>9v9tfhnd</td>
      <td>0.355513</td>
      <td></td>
      <td><a href="Topic_09.html#zbxiaofl">Tseng_2008</a>, <a href="Topic_09.html#hpuj1nvp">Wang_2019</a>, <a href="Topic_01.html#17f53neo">Escors_2014</a></td>
    </tr>
    <tr>
      <th id="rudsvyqd";>36</th>
      <td>Wang_2019</td>
      <td>Human LAP(+)GARP(+)FOXP3(+) regulatory T cells attenuate xenogeneic graft versus host disease</td>
      <td>Wang, Huihui; Song, Hyo; Pham, Anha V.; Cooper, Laurence J.; Schulze, Janika J.; Olek, Sven; Tran, Dat Q.</td>
      <td>2019</td>
      <td>2019-04-12</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531299" target="_blank">PMC6531299</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31149046.0" target="_blank">31149046.0</a></td>
      <td><a href="https://doi.org/10.7150/thno.30254" target="_blank">10.7150/thno.30254</a></td>
      <td>rudsvyqd</td>
      <td>0.352450</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#k751ryv4">Zhao_2011</a>, <a href="Topic_06.html#ivyp5cgz">Huang_2018</a></td>
      <td><a href="Topic_01.html#cxcsblpg">Bayry_2013</a>, <a href="Topic_01.html#qjezak5y">Wing_2013</a></td>
    </tr>
    <tr>
      <th id="2j6qzzs3";>37</th>
      <td>Ekiz_2019</td>
      <td>MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers</td>
      <td>Ekiz, H. Atakan; Huffaker, Thomas B.; Grossmann, Allie H.; Stephens, W. Zac; Williams, Matthew A.; Round, June L.; O’Connell, Ryan M.</td>
      <td>2019</td>
      <td>2019-02-05</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482995" target="_blank">PMC6482995</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30721153.0" target="_blank">30721153.0</a></td>
      <td><a href="https://doi.org/10.1172/jci.insight.126543" target="_blank">10.1172/jci.insight.126543</a></td>
      <td>2j6qzzs3</td>
      <td>0.346602</td>
      <td><a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="kbz6lfry";>38</th>
      <td>Wahl_2019</td>
      <td>Precision mouse models with expanded tropism for human pathogens</td>
      <td>Wahl, Angela; De, Chandrav; Fernandez, Maria Abad; Lenarcic, Erik M.; Xu, Yinyan; Cockrell, Adam S.; Cleary, Rachel A.; Johnson, Claire E.; Schramm, Nathaniel J.; Rank, Laura M.; Newsome, Isabel G.; Vincent, Heather A.; Sanders, Wes; Aguilera-Sandoval, Christian R.; Boone, Allison; Hildebrand, William H.; Dayton, Paul A.; Baric, Ralph S.; Pickles, Raymond J.; Braunstein, Miriam; Moorman, Nathaniel J.; Goonetilleke, Nilu; Garcia, J. Victor</td>
      <td>2019</td>
      <td>2019-08-26</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776695" target="_blank">PMC6776695</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31451733.0" target="_blank">31451733.0</a></td>
      <td><a href="https://doi.org/10.1038/s41587-019-0225-9" target="_blank">10.1038/s41587-019-0225-9</a></td>
      <td>kbz6lfry</td>
      <td>0.340582</td>
      <td><a href="Topic_01.html#742r5m9s">Kolls_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="b62ybp9w";>39</th>
      <td>Bao_M_2006</td>
      <td>Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide</td>
      <td>Bao, Musheng; Zhang, Yi; Wan, Min; Dai, Li; Hu, Xiaoping; Wu, Xiuli; Wang, Li; Deng, Ping; Wang, Junzhi; Chen, Jianzhu; Liu, Yongjun; Yu, Yongli; Wang, Liying</td>
      <td>2006</td>
      <td>2006-03-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110578" target="_blank">PMC7110578</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/16298165.0" target="_blank">16298165.0</a></td>
      <td><a href="https://doi.org/10.1016/j.clim.2005.09.014" target="_blank">10.1016/j.clim.2005.09.014</a></td>
      <td>b62ybp9w</td>
      <td>0.339139</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_02.html#wdbrxpmz">Swiecki_2010</a>, <a href="Topic_02.html#jwglalgx">Zuo_J_2009</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="1vjdvp8q";>40</th>
      <td>Zamame_Ramirez_2020</td>
      <td>Blocking drug-induced autophagy with chloroquine in HCT-116 colon cancer cells enhances DC maturation and T cell responses induced by tumor cell lysate</td>
      <td>Zamame Ramirez, Jofer Andree; Romagnoli, Graziela Gorete; Falasco, Bianca Francisco; Gorgulho, Carolina Mendonça; Sanzochi Fogolin, Carla; dos Santos, Daniela Carvalho; Junior, João Pessoa Araújo; Lotze, Michael Thomas; Ureshino, Rodrigo Portes; Kaneno, Ramon</td>
      <td>2020</td>
      <td>2020-07-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152898" target="_blank">PMC7152898</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/j.intimp.2020.106495" target="_blank">10.1016/j.intimp.2020.106495</a></td>
      <td>1vjdvp8q</td>
      <td>0.311777</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_02.html#jwglalgx">Zuo_J_2009</a></td>
      <td><a href="Topic_09.html#zbxiaofl">Tseng_2008</a>, <a href="Topic_09.html#ifnc53my">Peng_2011</a>, <a href="Topic_09.html#4jycukj3">Sher_2015</a></td>
    </tr>
    <tr>
      <th id="xd1wcito";>41</th>
      <td>Kim_H_2019</td>
      <td>T cell-selective deletion of Oct1 protects animals from autoimmune neuroinflammation while maintaining neurotropic pathogen response</td>
      <td>Kim, Heejoo; Dickey, Laura; Stone, Colleen; Jafek, Jillian L.; Lane, Thomas E.; Tantin, Dean</td>
      <td>2019</td>
      <td>2019-07-03</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607600" target="_blank">PMC6607600</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31266507.0" target="_blank">31266507.0</a></td>
      <td><a href="https://doi.org/10.1186/s12974-019-1523-3" target="_blank">10.1186/s12974-019-1523-3</a></td>
      <td>xd1wcito</td>
      <td>0.307717</td>
      <td><a href="Topic_12.html#uhg2bzlf">Hansen_2018</a>, <a href="Topic_06.html#kdfl6yfo">Koch_2012</a>, <a href="Topic_02.html#glm2dxhh">Hwang_2015</a>, <a href="Topic_06.html#ydu0l0st">Zhao_2012</a>, <a href="Topic_01.html#742r5m9s">Kolls_2012</a></td>
      <td><a href="Topic_01.html#ixgz4e7k">Rothhammer_2014</a></td>
    </tr>
  </tbody>
</table>
</body>
</html>
